Back
Allogene Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
11
ALLO
Allogene Therapeutics
Last Price:
2.09
Seasonality Move:
6.59%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALLO is experiencing slight selling pressure.
Allogene Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.46 | Sell |
| 20-day SMA: | 2.68 | Sell |
| 50-day SMA: | 2.72 | Sell |
| 200-day SMA: | 3.14 | Sell |
| 8-day EMA: | 2.38 | Sell |
| 20-day EMA: | 2.59 | Sell |
| 50-day EMA: | 2.67 | Sell |
| 200-day EMA: | 3.04 | Sell |
Allogene Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 31.82 | Sell |
| Chaikin Money Flow: | -488566 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.38 - 3.02) | Sell |
| Bollinger Bands (100): | (2.39 - 2.95) | Sell |
Allogene Therapeutics Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Allogene Therapeutics Stock
Is Allogene Therapeutics Stock a Buy?
- Allogene Therapeutics share price is 2.05 while ALLO 8-day simple moving average is 2.46, which is a Sell signal.
- The stock price of ALLO is 2.05 while Allogene Therapeutics 20-day SMA is 2.68, which makes it a Sell.
- Allogene Therapeutics 50-day simple moving average is 2.72 while ALLO share price is 2.05, making it a Sell technically.
- ALLO stock price is 2.05 and Allogene Therapeutics 200-day simple moving average is 3.14, creating a Sell signal.
ALLO Technical Analysis vs Fundamental Analysis
Sell
11
Allogene Therapeutics (ALLO)
is a Sell
Is Allogene Therapeutics a Buy or a Sell?
-
Allogene Therapeutics stock is rated a Sell
The current Allogene Therapeutics [ALLO] share price is $2.05. The Score for ALLO is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Allogene Therapeutics Stock Info
Market Cap:
429.83M
Price in USD:
2.05
Share Volume:
2.44M
Allogene Therapeutics 52-Week Range
52-Week High:
5.78
52-Week Low:
2.01
Sell
11
Allogene Therapeutics (ALLO)
is a Sell
Allogene Therapeutics Share Price Forecast
-
What is the Allogene Therapeutics stock price today?
The Allogene Therapeutics stock price is 2.05 USD today. -
Will ALLO stock go up or go down?
Allogene Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Allogene Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Allogene Therapeutics is overvalued.
Is Allogene Therapeutics Stock a Buy?
- Allogene Therapeutics share price is 2.05 while ALLO 8-day exponential moving average is 2.38, which is a Sell signal.
- The stock price of ALLO is 2.05 while Allogene Therapeutics 20-day EMA is 2.59, which makes it a Sell.
- Allogene Therapeutics 50-day exponential moving average is 2.67 while ALLO share price is 2.05, making it a Sell technically.
- ALLO stock price is 2.05 and Allogene Therapeutics 200-day simple moving average is 3.04, creating a Sell signal.
Fundamental Analysis of Allogene Therapeutics
Is Allogene Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $0.06 per share.
Technical Analysis of Allogene Therapeutics
Should I short Allogene Therapeutics stock?
- ALLO Moving Average Covergence Divergence (MACD) indicator is -0.14, suggesting Allogene Therapeutics is a Sell
- Allogene Therapeutics Relative Strength Index (RSI) is 31.82, which suggest Allogene Therapeutics is oversold
- The Bollinger Bands (25) for Allogene Therapeutics is (2.38 - 3.02), which suggest Allogene Therapeutics is a Sell
- The Bollinger Bands (100) for Allogene Therapeutics is (2.39 - 2.95), which suggest Allogene Therapeutics is a Sell
* Allogene Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.